Role of Imaging in Prostate Cancer
- PMID: 20161047
- PMCID: PMC2746671
- DOI: 10.1016/j.cpet.2009.05.003
Role of Imaging in Prostate Cancer
Similar articles
-
Role of multi-parametric (mp) MRI in prostate cancer.J Pak Med Assoc. 2018 Jan;68(1):98-104. J Pak Med Assoc. 2018. PMID: 29371727
-
Multiparametric-MRI in diagnosis of prostate cancer.Indian J Urol. 2015 Jul-Sep;31(3):194-201. doi: 10.4103/0970-1591.159606. Indian J Urol. 2015. PMID: 26166962 Free PMC article. Review.
-
Current role of multiparametric magnetic resonance imaging for prostate cancer.Quant Imaging Med Surg. 2015 Oct;5(5):754-64. doi: 10.3978/j.issn.2223-4292.2015.10.08. Quant Imaging Med Surg. 2015. Retraction in: Quant Imaging Med Surg. 2024 Mar 15;14(3):2736. doi: 10.21037/qims-2023-04. PMID: 26682144 Free PMC article. Retracted. Review.
-
Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.Radiology. 2010 Jul;256(1):176-83. doi: 10.1148/radiol.10091147. Epub 2010 May 26. Radiology. 2010. PMID: 20505068 Free PMC article.
-
Incorporating imaging into personalized medicine for the detection of prostate cancer: Pharmacological research-Urogenital pharmacology.Pharmacol Res. 2016 Dec;114:163-165. doi: 10.1016/j.phrs.2016.10.020. Epub 2016 Oct 21. Pharmacol Res. 2016. PMID: 27777131 Review.
Cited by
-
The diagnostic value of whole-body HYNIC-PSMA 11 -Tc [99 mTc] SPECT/CT scan in early staging of patients with moderate- and high-risk prostate cancer.Ann Nucl Med. 2025 Aug;39(8):833-846. doi: 10.1007/s12149-025-02055-2. Epub 2025 May 10. Ann Nucl Med. 2025. PMID: 40347415
-
Influence of (11)C-choline PET/CT on radiotherapy planning in prostate cancer.Rep Pract Oncol Radiother. 2014 Dec 16;20(2):104-12. doi: 10.1016/j.rpor.2014.11.008. eCollection 2015 Mar-Apr. Rep Pract Oncol Radiother. 2014. PMID: 25859399 Free PMC article.
-
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer.Sci Rep. 2017 Nov 23;7(1):16159. doi: 10.1038/s41598-017-16327-z. Sci Rep. 2017. PMID: 29170516 Free PMC article.
-
Role of ¹¹C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation.Jpn J Radiol. 2011 Jul;29(6):394-404. doi: 10.1007/s11604-011-0570-1. Epub 2011 Jul 24. Jpn J Radiol. 2011. PMID: 21786095
-
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.J Nucl Med. 2011 Jan;52(1):81-9. doi: 10.2967/jnumed.110.077941. Epub 2010 Dec 13. J Nucl Med. 2011. PMID: 21149473 Free PMC article. Review.
References
-
- Benaron DA. The future of cancer imaging. Cancer Metastasis Rev. 2002;21:45–78. - PubMed
-
- SEER: The Surveillance, Epidemiology, and End Results Program — based within the Surveillance Research Program (SRP) at the National Cancer Institute. 2008. ( http://seer.cancer.gov/statfacts/html/prost.html)
-
- Frank IN, Graham S, Jr, Nabors WL. Urologic and Male Genital Cancers. In: Holleb AI, Fink DJ, Murphy GP, editors. Clinical Oncology. Atlanta: American Cancer Society; 1991. pp. 280–283.
-
- Kessler B, Albertsen P. The natural history of prostate cancer. Urol Clin North Am. 2003;30:219–226. - PubMed
-
- Small EJ. Prostate cancer: incidence, management and outcomes. Drugs Aging. 1998;13:71–81. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical